Consolidated Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Product sales, net	$ 2,232,420	$ 2,248,845
Cost of products sold	584,985	572,742
Gross profit	1,647,435	1,676,103
Selling, general and administrative expenses	3,256,728	3,035,276
Research and development expenses	369,120	94,211
Depreciation and amortization expense	19,440	11,684
Total operating expenses	3,645,288	3,141,171
Loss from operations	(1,997,853)	(1,465,068)
Interest income	3,267	24,539
Loss before provision for income taxes	(1,994,586)	(1,440,529)
Net loss	$ (1,994,586)	$ (1,440,529)
Net loss per share applicable to common stockholders—
Basic and Diluted (in dollars per share)	$ (0.02)	$ (0.02)
Weighted average shares outstanding and to be issued—
Basic and diluted (in shares)	81,854,512	79,738,551